PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31883408-2 2020 The aim of this study was to investigate the role of farnesoid X receptor (FXR) in 1-deoxysphingolipid de novo synthesis and degradation. amphetaminil 83-102 nuclear receptor subfamily 1, group H, member 4 Mus musculus 53-73 31883408-2 2020 The aim of this study was to investigate the role of farnesoid X receptor (FXR) in 1-deoxysphingolipid de novo synthesis and degradation. amphetaminil 83-102 nuclear receptor subfamily 1, group H, member 4 Mus musculus 75-78 31883408-8 2020 FXR activation by OCA protected the liver against oxidative stress, apoptosis, and reduced 1-deoxysphingolipid levels, both in a HFD-induced mouse model of obesity and in 1-deoxysphinganine-treated mice. amphetaminil 91-110 nuclear receptor subfamily 1, group H, member 4 Mus musculus 0-3 31883408-9 2020 In vitro, FXR activation lowered intracellular 1-deoxysphingolipid levels by inducing Cyp4f -mediated degradation, but not by inhibiting de novo synthesis, thereby protecting hepatocytes against doxSA-induced cytotoxicity, mitochondrial damage, and apoptosis. amphetaminil 47-66 nuclear receptor subfamily 1, group H, member 4 Mus musculus 10-13 31883408-11 2020 Treatment with the Cyp4f pan-inhibitor HET0016 or FXR knockdown fully abolished the protective effect of OCA, indicating that OCA-mediated 1-deoxysphingolipid degradation is FXR- and Cyp4f-dependent. amphetaminil 139-158 nuclear receptor subfamily 1, group H, member 4 Mus musculus 50-53 31883408-11 2020 Treatment with the Cyp4f pan-inhibitor HET0016 or FXR knockdown fully abolished the protective effect of OCA, indicating that OCA-mediated 1-deoxysphingolipid degradation is FXR- and Cyp4f-dependent. amphetaminil 139-158 nuclear receptor subfamily 1, group H, member 4 Mus musculus 174-177 31883408-12 2020 CONCLUSIONS: Our study identifies FXR-Cyp4f as a novel regulatory pathway for 1-deoxysphingolipid metabolism. amphetaminil 78-97 nuclear receptor subfamily 1, group H, member 4 Mus musculus 34-37